Princeton BioPharma Capital Partners

Princeton BioPharma Capital Partners is a private equity firm providing growth capital to commercial-stage healthcare companies. It focuses on established biopharma and medical device entities with validated products, aiming to accelerate market expansion, optimize operations, and secure market share. The firm acts as a financial partner for scaling mature healthcare innovations.

Founded in 2010 and based in Bridgewater, New Jersey, the firm emerged from an understanding that commercial-stage healthcare businesses need specialized financial backing to transition from product validation to broader market penetration. This insight drove the creation of an investment vehicle to fulfill this critical capital requirement.

Princeton BioPharma Capital Partners supports a diverse portfolio of healthcare companies needing strategic investment for late-stage development and commercial growth. Its vision is to be a principal enabler of advanced medical solutions, fostering high-impact biotechnologies and pharmaceuticals. The firm aims to empower companies for sustained success and widespread societal benefit.